Avro Life Science
Waterloo, CanadaFounded 20168+ employeesPrivate
$2.2M raisedVenture· last: series unknown (Jan 2021)· 6 rounds
Backed by(20 investors)
Avro Life Science is developing skin patches for generic drug delivery, focusing on therapeutics for children and the elderly. The core of our technology is a novel biopolymer which is used as a platform for passive transdermal drug delivery of small molecules and drugs.
